Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2013 May 24:39:33.
doi: 10.1186/1824-7288-39-33.

A neonatal case of 3-hydroxy-3-methylglutaric-coenzyme A lyase deficiency

Case Reports

A neonatal case of 3-hydroxy-3-methylglutaric-coenzyme A lyase deficiency

Francesca Santarelli et al. Ital J Pediatr. .

Abstract

3-hydroxy-3-methylglutaric aciduria (OMIM 246450) is a rare autosomal recessive inborn of metabolism due to the deficiency of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) lyase, an enzyme involved both in the ketogenic pathway and leucine catabolism. Acute decompensations present with lethargy, cianosis, hypotonia, vomiting and metabolic acidosis with hypoketotic hypoglycemia. We report the case of a 3 days male with sudden hypoglycemic crisis initially misdiagnosed as a sepsis. HMG-CoA lyase deficiency was achieved through acyl-carnitines profile (showing a typical increasing of 3-hydroxy-isovaleryl and 3-methylgluraryl carnitines) and urinary organic acids analysis (disclosing elevation of 3-hydroxy-3-methylglutaric, 3-methyl-glutaconic, 3-methylglutaric and 3-hydroxyisovaleric acids). This case underlines the need of suspecting such inborn metabolic disorder in cases with hypoglycemia and metabolic acidosis. Acyl-carnitine and urinary organic acids profiles are essential to achieve a prompt diagnosis of treatable metabolic disorders in order to prevent their acute crisis with serious or even fatal consequences.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Acyl-carnitine profile revealing a typical increasing in 3-Hydroxy isovaleryl- carnitine (C5-OH) and 3-Methylglutaryl-carnitine (C6-DC) concentrations.
Figure 2
Figure 2
Urinary organic acids profile with evident increasing in 3-hydroxy-isovaleric, 3-methylglutaric, glutaric, 3-methyl-glutaconic, 3-hydroxy-3-methyl-glutaric acids and 3-methyl-crotonyl-glicine.

Similar articles

Cited by

References

    1. Reima S, Morgado C, Almeida IT, Silva M, Corte Real M, Campos J. 3-Hydroxy-3-methylglutaryl-coenzyme A lyase deficiency: Initial presentation in a young adult. JIMD Short Report. 2009;#152 Online doi: 10.1007/s10545-009-1048-5. - DOI - PubMed
    1. Pie J, Lopez-Vinas E, Puisac B, Menao S, Pié A, Casale C, Ramos FJ, Hegardt FG, Gomez-Puertas P, Casals N. Molecular genetics of HMG-CoA lyase deficiency. Mol Genet Metab. 2007;92:198–209. doi: 10.1016/j.ymgme.2007.06.020. - DOI - PubMed
    1. Urganci N, Arapoglu M, Evrüke M, Aydin A. A Rare Cause of Hepatomegaly: 3-Hydroxy-3-Methylglutaryl Coenzyme-A Lyase Deficiency. Pediatr Gastroenterol Nutr. 2001;33:3. - PubMed
    1. Digest IEM. Disorders of ketone production and utilization. Mol Genet Metab. 2006;87:281–283. - PubMed
    1. Leung AAL, Chan AK, Ezekowitz JA, Leung AKC. A Case of Dilated Cardiomyopathy Associated with 3-Hydroxy-3-Methylglutaryl-Coenzyme A (HMG CoA) Lyase Deficiency. Case Reports in Medicine. 2009. - DOI - PMC - PubMed

Publication types

Supplementary concepts